UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

The effect of warfarin administration on platelet aggregation

Bratislavské lékarské listy, 2021, Vol.122 (5), p.320-324

2021

Volltextzugriff (PDF)

The impact of gender on outcomes of patients with ST elevation myocardial infarction transported for percutaneous coronary intervention: analysis of the PRAGUE-1 and 2 studies

Heart (British Cardiac Society), 2008-03, Vol.94 (3), p.e5-e5

2008

Volltextzugriff (PDF)

Trombosis del stent tras la ICP por SCA: ¿la adherencia al tratamiento antiagregante implica más que su intensidad?

Revista española de cardiologia, 2019-04, Vol.72 (4), p.282-284

Motovska, Zuzana

2019

Volltextzugriff (PDF)

397. Perioperative disorders of hemostasis in cardiac patients in oncosurgery

European journal of surgical oncology, 2014-11, Vol.40 (11), p.S153-S153

2014

Volltextzugriff (PDF)

Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

Circulation (New York, N.Y.), 2021, Vol.144 (18), p.1476-1484

2021

Volltextzugriff (PDF)

THA and TKA in patients with cardiovascular disease: What makes the risk of perioperative bleeding?

Bratislavské lékarské listy, 2016-01, Vol.117 (11), p.628-630

2016

Volltextzugriff (PDF)

Comparison of ticagrelor and prasugrel just before PCI in NSTE acute coronary syndromes, LIKE-ACCOAST analysis

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Impact of COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

All-cause mortality of patients with STEMI, cardiogenic shock and multivessel coronary disease treated with culprit vessel only versus multivessel primary PCI

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

Incidence and prediction of periprocedural myocardial infarction in elective PCI: the ALPHEUS-MI sub-study

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Appropriate ischemic criteria for type 4a myocardial infarction: insights from the ALPHEUS trial

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Ticagrelor or Clopidogrel to reduce ischemic events after Percutaneous Coronary Intervention in chronic coronary syndrome in clopidogrel naive patient: the ALPHEUS Naive sub-study

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

P2Y12 inhibitor loading time before elective PCI and the prevention of myocardial necrosis

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

Ticagrelor versus clopidogrel for complex percutaneous coronary intervention in chronic coronary syndrome: a post-hoc analysis of the ALPHEUS study

European heart journal, 2023-11, Vol.44 (Supplement_2)

2023

Volltextzugriff (PDF)

CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in prasugrel- or ticagrelor-treated STEMI patients: monocentric study in PRAGUE-18 trial participants

Xenobiotica, 2020-08, Vol.50 (8), p.929-938

2020

Volltextzugriff (PDF)

Haematological manifestation of coeliac disease in a young patient with myocardial infarction

Internal medicine journal, 2009-10, Vol.39 (10), p.704-706

2009

Volltextzugriff (PDF)

Prognostic Value of MicroRNAs in Patients after Myocardial Infarction: A Substudy of PRAGUE-18

Disease markers, 2019, Vol.2019, p.2925019-9

2019

Volltextzugriff (PDF)

Clinical outcomes with drug-eluting stents, bare-metal stents, and bioresorbable scaffolds implanted in patients with AMI treated with primary PCI. Data from the Prague-18 trial

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

Appropriate ischemic criteria for type 4a myocardial infarction: Insights from the ALPHEUS trial

Archives of cardiovascular diseases, 2024-01, Vol.117 (1), p.S4-S5

2024

Volltextzugriff (PDF)

P3310Genetic variations associated with increased bleeding risk may improve the pre-procedural bleeding risk stratification: an analysis of polymorphisms of key platelet receptors

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

P1727Prognosis predictors of patients with initial cardiogenic shock complicated acute myocardial infarction treated with primary angioplasty and intense antiplatelet therapy. PRAGUE-18 shock substudy

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

3300MiR-126-3P and MiR-223-3p in Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty, The Prague-18 Genetic Sub-study

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

P4786Dual antithrombotic therapy is similarly effective to triple therapy in preventing thrombotic events in patients with atrial fibrillation and acute coronary syndrome

European heart journal, 2019-10, Vol.40 (Supplement_1)

2019

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(57)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(21)
Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Male
(12)
Female
(10)
Cardiovascular System & Cardiology
(9)
Middle Aged
(9)
Aged
(8)
Cardiac & Cardiovascular Systems
(8)
Risk Factors
(6)
Treatment Outcome
(6)
Heart Attacks
(5)
Mortality
(5)
Myocardial Infarction
(5)
Myocardial Infarction - Drug Therapy
(5)
Adult
(4)
Cardiology
(4)
Cardiovascular Disease
(4)
General & Internal Medicine
(4)
Medicin Och Hälsovetenskap
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The effect of warfarin administration on platelet aggregation

The impact of gender on outcomes of patients with ST elevation myocardial infarction transported for percutaneous coronary intervention: analysis of the PRAGUE-1 and 2 studies

Trombosis del stent tras la ICP por SCA: ¿la adherencia al tratamiento antiagregante implica más que su intensidad?

397. Perioperative disorders of hemostasis in cardiac patients in oncosurgery

Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

THA and TKA in patients with cardiovascular disease: What makes the risk of perioperative bleeding?

Comparison of ticagrelor and prasugrel just before PCI in NSTE acute coronary syndromes, LIKE-ACCOAST analysis

Impact of COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction

All-cause mortality of patients with STEMI, cardiogenic shock and multivessel coronary disease treated with culprit vessel only versus multivessel primary PCI

Incidence and prediction of periprocedural myocardial infarction in elective PCI: the ALPHEUS-MI sub-study

Appropriate ischemic criteria for type 4a myocardial infarction: insights from the ALPHEUS trial

Ticagrelor or Clopidogrel to reduce ischemic events after Percutaneous Coronary Intervention in chronic coronary syndrome in clopidogrel naive patient: the ALPHEUS Naive sub-study

P2Y12 inhibitor loading time before elective PCI and the prevention of myocardial necrosis

Ticagrelor versus clopidogrel for complex percutaneous coronary intervention in chronic coronary syndrome: a post-hoc analysis of the ALPHEUS study

CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in prasugrel- or ticagrelor-treated STEMI patients: monocentric study in PRAGUE-18 trial participants

Haematological manifestation of coeliac disease in a young patient with myocardial infarction

Prognostic Value of MicroRNAs in Patients after Myocardial Infarction: A Substudy of PRAGUE-18

Clinical outcomes with drug-eluting stents, bare-metal stents, and bioresorbable scaffolds implanted in patients with AMI treated with primary PCI. Data from the Prague-18 trial

Appropriate ischemic criteria for type 4a myocardial infarction: Insights from the ALPHEUS trial

Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction - insights from the IAMI trial

P3310Genetic variations associated with increased bleeding risk may improve the pre-procedural bleeding risk stratification: an analysis of polymorphisms of key platelet receptors

P1727Prognosis predictors of patients with initial cardiogenic shock complicated acute myocardial infarction treated with primary angioplasty and intense antiplatelet therapy. PRAGUE-18 shock substudy

3300MiR-126-3P and MiR-223-3p in Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty, The Prague-18 Genetic Sub-study

P4786Dual antithrombotic therapy is similarly effective to triple therapy in preventing thrombotic events in patients with atrial fibrillation and acute coronary syndrome

Optimal timing of influenza vaccination among patients with acute myocardial infarction - Findings from the IAMI trial

Suchergebnisse filtern